Immunology of Infection with the Human Immunodeficiency Virus (HIV)
Authors: Scott Koenig, Zeda F. Rosenberg
Journal: Annals of Internal Medicine (1987)

Editorials1 September 1987Immunology of Infection with the Human Immunodeficiency Virus (HIV)A View from the III International Conference on AIDSSCOTT KOENIG, Ph.D., M.D., ZEDA F. ROSENBERG, Sc.DSCOTT KOENIG, Ph.D., M.D.Search for more papers by this author, ZEDA F. ROSENBERG, Sc.DSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-107-2-409 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptThe virulence of the human immunodeficiency virus (HIV) lies in its unique ability to disarm the system that provides protection against invasive pathogens completely. The virus devastates the immune system by eliminating the T4 lymphocyte, which is the key component for generating and regulating the immune response (1). The T4 lymphocytes that do survive cannot execute the functions they were programmed to perform. The macrophage, a critical element in the generation of a specific immune response, can also be infected with HIV (2) and may serve as an important viral reservoir in the infected host (3, 4). Investigators are trying...References1. FAUCIMASURGELMANNMARKHAMHAHNLANE AHEPBH. The acquired immunodeficiency syndrome: an update. Ann Intern Med. 1985;102:800-13. LinkGoogle Scholar2. GARTNERMARKOVITSMARKOVITSKAPLANGALLOPOPOVIC SPDMRM. The role of mononuclear phagocytes in HTLV-III/ LAV infection. Science. 1986;233:215-9. CrossrefMedlineGoogle Scholar3. KOENIGGENDELMANORENSTEIN SHJ. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science. 1986;233:1089-93. CrossrefMedlineGoogle Scholar4. WILEYSCHRIERNELSONLAMPERTOLDSTONE CRJPM. Cellular localization of human immunodeficiency virus infection within the brains of acquired immunodeficiency syndrome patients. Proc Natl Acad Sci USA. 1986;83:7089-93. CrossrefMedlineGoogle Scholar5. PAHWAPAHWAGOODGALLOSAXINGER SRRRC. Stimulatory and inhibitory influences of human immunodeficiency virus on normal B lymphocytes. Proc Natl Acad Sci USA. 1986;83:9124-8. CrossrefMedlineGoogle Scholar6. ROBERT-GUROFFBROWNGALLO MMR. HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex. Nature. 1985;316:72-4. CrossrefMedlineGoogle Scholar7. WEISSCLAPHAMCHEINGSONG-POPOV RPR. Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients. Nature. 1985;316:69-72. CrossrefMedlineGoogle Scholar8. WEISSCLAPHAMWEBERDALGLEISHLASKYBERMAN RPJALP. Variable and conserved neutralization antigens of human immunodeficiency virus. Nature. 1986;324:572-5. CrossrefMedlineGoogle Scholar9. LOONEYFISHERREDFIELDBURKEGALLOWONGSTAAL DARDRF. Correlation of clinical status and neutralizing activity of sera of patients infected with HTLV-III/HIV [Abstract]. In: III International Conference on Acquired Immunodeficiency Syndrome (AIDS). Washington, D.C.: U.S. Department of Health and Human Services; 1987:107. Google Scholar10. RANKIANTONENVALLEALLAINKROHN AJSJK. Characterization of the latent period and the development of neutralizing antibodies in early sexually transmitted HIV infection [Abstract]. In: III International Conference on Acquired Immunodeficiency Syndrome (AIDS). Washington, D.C.: U.S. Department of Health and Human Services; 1987:30. Google Scholar11. AHEARNEWEINHOLDMATTHEWS PKT. Cellular immune response to viral peptides in patients exposed to HIV [Abstract]. In: III International Conference on Acquired Immunodeficiency Syndrome (AIDS). Washington, D.C.: U.S. Department of Health and Human Services; 1987:8. Google Scholar12. CEASEMARGALITCORNETTE KHJ. Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide. Proc Natl Acad Sci USA. 1987;84:4249-53. CrossrefMedlineGoogle Scholar13. MATTHEWSLANGLOISROBEY TAW. Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein. Proc Natl Acad Sci USA. 1986;83:9709-13. CrossrefMedlineGoogle Scholar14. LASKYGROOPMANFENNIE LJC. Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein. Science. 1986;233:209-12. CrossrefMedlineGoogle Scholar15. PUTNEYMATTHEWSROBEY STW. HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope. Science. 1986;234:1392-5. CrossrefMedlineGoogle Scholar16. NARAROBEYGONDACARTERFISCHINGER PWMSP. Absence of cytotoxic antibody to human immunodeficiency virus-infected cells in humans and its induction in animals after infection or immunization with purified envelope glycoprotein gp120. Proc Natl Acad Sci USA. 1987;84:3797-801. CrossrefMedlineGoogle Scholar17. CLAPHAMWEBERMONTAGNIERWEISS PJLR. Common and variable neutralizing antigens of HIV-1 and HIV-2 [Abstract]. In: III International Conference on Acquired Immunodeficiency Syndrome (AIDS). Washington, D.C.: U.S. Department of Health and Human Services; 1987:8. Google Scholar18. SMITHCOCHRANERICSON GGB. Full-length and truncated HIV envelope polypeptides produced in an insect cell expression system elicit high titer neutralizing antibodies in animals [Abstract]. In: III International Conference on Acquired Immunodeficiency Syndrome (AIDS). Washington, D.C.: U.S. Department of Health and Human Services; 1987:107. Google Scholar19. MATSUSHITAKOITOSUTOHHATTORIROBERT-GURHOFFTAKATSUKI SAHTK. A neutralizing monoclonal antibody reactive against an external envelope glycoprotein of HTLV-III/LAV (human immunodeficiency virus) [Abstract]. In: III International Conference on Acquired Immunodeficiency Syndrome (AIDS). Washington, D.C.: U.S. Department of Health and Human Services; 1987:106. Google Scholar20. KROHNROBEYPUTNEY KWS. Specific cellular immune response and neutralizing antibodies in goats immunized with native or recombinant envelope proteins derived from human T-lymphotropic virus type IIIB and in human immunodeficiency virus-infected men. Proc Natl Acad Sci USA. 1987;84:4994-8. CrossrefMedlineGoogle Scholar21. ZAGURYLURHUMAMBAYO DZK. Experimental immune activation against AIDS virus in humans [Abstract]. In: III International Conference on Acquired Immunodeficiency Syndrome (AIDS). Washington, D.C.: U.S. Department of Health and Human Services; 1987:62. Google Scholar22. NARAARTHURROBEYFISCHINGERASHER PLWPD. Persistent HTLV-IIIb and LAV infection in chimpanzees: its effect on virus biochemistry and serology [Abstract]. In: III International Conference on Acquired Immunodeficiency Syndrome (AIDS). Washington, D.C.: U.S. Department of Health and Human Services; 1987:110. Google Scholar23. FISCHINGERROBEYKOPROWSKIGALLOBOLOGNESI PWHRD. Current status and strategies for vaccines induced by human T-cell lymphotropic retroviruses. Cancer Res. 1985;45:4694s-99s. MedlineGoogle Scholar24. WALKERCHAKRABARTIMOSS BSB. HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature. 1987;328:345-8. CrossrefMedlineGoogle Scholar25. SHEPPMANNCHAKRABARTIMOSSDAGUILLARDQUINNAN DDSBFG. Detection of HLA restricted human immunodeficiency virus (HIV) envelope antigen-specific cytotoxic lymphocytes (CTL) [Abstract]. In: III International Conference on Acquired Immunodeficiency Syndrome (AIDS). Washington, D.C.: U.S. Department of Health and Human Services; 1987:59. Google Scholar26. KOENIGEARLPOWELL SPD. Cytotoxic T cells directed against target cells expressing HIV-1 proteins [Abstract]. In: III International Conference on Acquired Immunodeficiency Syndrome (AIDS). Washington, D.C.: U.S. Department of Health and Human Services; 1987:59. Google Scholar27. ZARLINGMORANMCCLURESRIDHAREICHBERGHU JPJPJS. Cytotoxic T cells, that recognize human immunodeficiency virus (HIV) envelope glycoproteins, isolated from chimpanzees immunized with a recombinant vaccinia virus expressing HIV glycoproteins [Abstract]. In: III International Conference on Acquired Immunodeficiency Syndrome (AIDS). Washington, D.C.: U.S. Department of Health and Human Services; 1987:59. Google Scholar28. ZARLINGMORTONMORANMCCLUREKOSOWSKIHU JWPJSS. T-cell responses to human AIDS virus in macaques immunized with recombinant vaccinia virus. Nature. 1986;323:344-6. CrossrefMedlineGoogle Scholar29. LYERLYMATTHEWSLANGLOISBOLOGNESIWEINHOLD HTADK. Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack. Proc Natl Acad Sci USA. 1987;84:4601-5. CrossrefMedlineGoogle Scholar30. OJO-AMAIZE EA NISHANIAN PG DEITH D JR FAHEY JL GIORGI JV . HIV antibodies in human sera induce cell-mediated lysis of HIV-infected cells [Abstract]. In: III International Conference on Acquired Immunodeficiency Syndrome (AIDS). Washington, D.C.: U.S. Department of Health and Human Services; 1987:59. Google Scholar31. ROOKLANEFOLKSMCCOYALTERFAUCI AHTSHA. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells. J Immunol. 1987;138:1064-7. MedlineGoogle Scholar32. CHANHDREESMANKENNEDY TGR. Monoclonal anti-idiotypic antibody mimics the CD4 receptor and binds human immunodeficiency virus. Proc Natl Acad Sci USA. 1987;84:3891-5. CrossrefMedlineGoogle Scholar33. SATTENTAUWEBERWEISSBEVERLEY QJRP. Antisera to Leu 3a with anti-idiotypic activity react with gp110/130 of HIV-1 and LAV-2 [Abstract]. In: III International Conference on Acquired Im munodeficiency Syndrome (AIDS). Washington, D.C.: U.S. Department of Health and Human Services; 1987:160. Google Scholar34. NORRBYBIBERFELDALBERTCHIOIDFLJUNGGRENFENYO EGJFKE. Significance of variation between human immunodeficiency (HIV) isolates for serology and vaccine development [Abstract]. In: III International Conference on Acquired Immunodeficiency Syndrome (AIDS). Washington, D.C.: U.S. Department of Health and Human Services; 1987:1. Google Scholar35. LJUNGGRENFENYOBOTTIGERBIBERFELDJONDAL KEBGM. Antibody-dependent cellular cytotoxicity (ADCC)-inducing antibodies against human immunodeficiency virus (HIV) [Abstract]. In: III International Conference on Acquired Immunodeficiency Syndrome (AIDS). Washington, D.C.: U.S. Department of Health and Human Services; 1987:8. Google Scholar36. MANNLESANEBLATTNERPOPOVIC DFWM. HLA-DR is involved in the HIV receptor [Abstract]. In: III International Conference on Acquired Immunodeficiency Syndrome (AIDS). Washington, D.C.: U.S. Department of Health and Human Services; 1987:209. Google Scholar37. GOLDINGROBEYGATESLINDNERGOLDING HFFWB. Homologous peptides from HIV P41 and HLA class II bind CD4 on human T cells [Abstract]. In: III International Conference on Acquired Immunodeficiency Syndrome (AIDS). Washington, D.C.: U.S. Department of Health and Human Services; 1987:209. Google Scholar38. LANEDUKOVICHMCCARTHYFAUCIGREENE HMSAW. Altered IL-2 gene expression in HIV infected peripheral blood CD4 + lymphocytes: possible mechanism for virus induced T cell death for the immunopathogenesis of AIDS [Abstract]. In: III International Conference on Acquired Immunodeficiency Syndrome (AIDS). Washington, D.C.: U.S. Department of Health and Human Services; 1987:209. Google Scholar39. LEVY J. Pathogenesis of HIV infection—virus: Lost interactions [Abstract]. In: III International Conference on Acquired Immunodeficiency Syndrome (AIDS). Washington, D.C.: U.S. Department of Health and Human Services; 1987:2. Google Scholar40. STRICKERMCHUGHMOODY RTD. An AIDS-related cytotoxic autoantibody reacts with a specific antigen on stimulated CD4+ T cells. Nature. 1987;327:710-3. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByAcquired Immune Deficiency Syndrome and the LungCorrection: Immunology of Infection with the Human Immunodeficiency Virus (HIV): A View from the III International Conference on AIDSCurrent Concepts in the Virology of Infection with Human Immunodeficiency Virus (HIV) A View from the III International Conference on AIDSJAMES A. HOXIE, M.D. 1 September 1987Volume 107, Issue 3Page: 409-412KeywordsHIVHIV infectionsImmune responseImmune systemImmunologyLymphocytesMacrophagesPathogens Issue Published: 1 September 1987 PDF DownloadLoading ...